Toronto - Delayed Quote • CAD
Profound Medical Corp. (PRN.TO)
At close: April 23 at 2:55 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,199.00
7,199.00
6,681.00
6,873.00
7,304.00
Cost of Revenue
2,817.00
2,817.00
3,660.00
3,921.00
3,830.00
Gross Profit
4,382.00
4,382.00
3,021.00
2,952.00
3,474.00
Operating Expense
32,998.00
32,998.00
32,623.00
33,243.00
22,337.00
Operating Income
-28,616.00
-28,616.00
-29,602.00
-30,291.00
-18,863.00
Net Non Operating Interest Income Expense
726.00
726.00
919.00
-310.00
149.00
Other Income Expense
-807.00
-807.00
301.00
7.00
-2,863.00
Pretax Income
-28,697.00
-28,697.00
-28,382.00
-30,594.00
-21,577.00
Tax Provision
-128.00
-128.00
287.00
105.00
45.00
Net Income Common Stockholders
-28,569.00
-28,569.00
-28,669.00
-30,699.00
-21,622.00
Diluted NI Available to Com Stockholders
-28,569.00
-28,569.00
-28,669.00
-30,699.00
-21,622.00
Basic EPS
-1.35
--
-1.38
-1.50
-1.25
Diluted EPS
-1.35
--
-1.38
-1.50
-1.25
Basic Average Shares
21,182.56
--
20,829.86
20,466.00
17,294.65
Diluted Average Shares
21,182.56
--
20,829.86
20,466.00
17,294.65
Total Operating Income as Reported
-28,616.00
-28,616.00
-32,126.00
-30,291.00
-18,863.00
Rent Expense Supplemental
715.00
715.00
496.00
--
--
Total Expenses
35,815.00
35,815.00
36,283.00
37,164.00
26,167.00
Net Income from Continuing & Discontinued Operation
-28,569.00
-28,569.00
-28,669.00
-30,699.00
-21,622.00
Normalized Income
-27,765.60
-27,765.60
-28,891.11
-30,704.15
-19,517.70
Interest Income
1,642.00
1,642.00
803.00
205.00
692.00
Interest Expense
770.00
770.00
174.00
67.00
543.00
Net Interest Income
726.00
726.00
919.00
-310.00
149.00
EBIT
-27,927.00
-27,927.00
-28,208.00
-30,527.00
-21,034.00
EBITDA
-26,781.00
-26,781.00
-26,604.00
-28,648.00
-19,496.00
Reconciled Cost of Revenue
2,817.00
2,817.00
3,660.00
3,921.00
3,830.00
Reconciled Depreciation
1,146.00
1,146.00
1,604.00
1,879.00
1,538.00
Net Income from Continuing Operation Net Minority Interest
-28,569.00
-28,569.00
-28,669.00
-30,699.00
-21,622.00
Total Unusual Items Excluding Goodwill
-807.00
-807.00
301.00
7.00
-2,863.00
Total Unusual Items
-807.00
-807.00
301.00
7.00
-2,863.00
Normalized EBITDA
-25,974.00
-25,974.00
-26,905.00
-28,655.00
-16,633.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-3.60
-3.60
78.89
1.86
-758.70
12/31/2020 - 7/10/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OFIX Orthofix Medical Inc.
13.22
+1.07%
TMD.TO Titan Medical Inc.
0.0600
0.00%
CODX Co-Diagnostics, Inc.
1.1500
0.00%
PRCT PROCEPT BioRobotics Corporation
53.75
+5.00%
PHG Koninklijke Philips N.V.
21.01
+1.94%
SWAV Shockwave Medical, Inc.
328.54
-0.02%
EW Edwards Lifesciences Corporation
87.75
+0.91%
BSX Boston Scientific Corporation
68.99
+1.43%
DXCM DexCom, Inc.
134.00
+1.89%
INMD InMode Ltd.
17.37
+1.34%